Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;17(2):125-30.
doi: 10.1007/s10048-015-0469-6. Epub 2015 Dec 12.

Slc20a2 is critical for maintaining a physiologic inorganic phosphate level in cerebrospinal fluid

Affiliations

Slc20a2 is critical for maintaining a physiologic inorganic phosphate level in cerebrospinal fluid

Nina Jensen et al. Neurogenetics. 2016 Apr.

Abstract

Mutations in the SLC20A2-gene encoding the inorganic phosphate (Pi) transporter PiT2 can explain approximately 40% of the familial cases of the rare neurodegenerative disorder primary familial brain calcification (Fahr's disease). The disease characteristic, cerebrovascular-associated calcifications, is also present in Slc20a2-knockout (KO) mice. Little is known about the specific role(s) of PiT2 in the brain. Recent in vitro studies, however, suggest a role in regulation of the [Pi] in cerebrospinal fluid (CSF). We here show that Slc20a2-KO mice indeed have a high CSF [Pi] in agreement with a role of PiT2 in Pi export from the CSF. The implications in relation to disease mechanism are discussed.

Keywords: Cerebrospinal fluid; Fahr’s disease; Inorganic phosphate; Primary familial brain calcification; SLC20A1; SLC20A2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
[Pi] in serum and CSF from 3-week-old WT and Slc20a2-KO mice. a CSF sampled from 11 WT (8 females, 3 males) and 10 KO (8 females, 2 males). b Serum sampled from 14 WT (10 females, 4 males) and 12 KO (9 females, 3 males). KO compared to WT: CSF [Pi] (p < 0.000001) and serum [Pi] (p < 0.01)

Comment in

References

    1. Wang C, Li Y, Shi L, Ren J, Patti M, Wang T, de Oliveira JR, Sobrido MJ, Quintans B, Baquero M, Cui X, Zhang XY, Wang L, Xu H, Wang J, Yao J, Dai X, Liu J, Zhang L, Ma H, Gao Y, Ma X, Feng S, Liu M, Wang QK, Forster IC, Zhang X, Liu JY. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet. 2012;44:254–256. doi: 10.1038/ng.1077. - DOI - PubMed
    1. Hsu SC, Sears RL, Lemos RR, Quintans B, Huang A, Spiteri E, Nevarez L, Mamah C, Zatz M, Pierce KD, Fullerton JM, Adair JC, Berner JE, Bower M, Brodaty H, Carmona O, Dobricic V, Fogel BL, Garcia-Estevez D, Goldman J, Goudreau JL, Hopfer S, Jankovic M, Jauma S, Jen JC, Kirdlarp S, Klepper J, Kostic V, Lang AE, Linglart A, Maisenbacher MK, Manyam BV, Mazzoni P, Miedzybrodzka Z, Mitarnun W, Mitchell PB, Mueller J, Novakovic I, Paucar M, Paulson H, Simpson SA, Svenningsson P, Tuite P, Vitek J, Wetchaphanphesat S, Williams C, Yang M, Schofield PR, de Oliveira JR, Sobrido MJ, Geschwind DH, Coppola G. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics. 2013;14:11–22. doi: 10.1007/s10048-012-0349-2. - DOI - PMC - PubMed
    1. Yamada M, Tanaka M, Takagi M, Kobayashi S, Taguchi Y, Takashima S, Tanaka K, Touge T, Hatsuta H, Murayama S, Hayashi Y, Kaneko M, Ishiura H, Mitsui J, Atsuta N, Sobue G, Shimozawa N, Inuzuka T, Tsuji S, Hozumi I. Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan. Neurology. 2014;82:705–712. doi: 10.1212/WNL.0000000000000143. - DOI - PubMed
    1. Ferreira JB, Pimentel L, Keasey MP, Lemos RR, Santos LM, Oliveira MF, Santos S, Jensen N, Teixeira K, Pedersen L, Rocha CR, Dias da Silva MR, Oliveira JR. First report of a de novo mutation at SLC20A2 in a patient with brain calcification. J Mol Neurosci. 2014;54:748–751. doi: 10.1007/s12031-014-0357-9. - DOI - PubMed
    1. Kasuga K, Konno T, Saito K, Ishihara A, Nishizawa M, Ikeuchi T. A Japanese family with idiopathic basal ganglia calcification with novel SLC20A2 mutation presenting with late-onset hallucination and delusion. J Neurol. 2014;261:242–244. doi: 10.1007/s00415-013-7205-7. - DOI - PubMed

Publication types

Substances